Rennova Health, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 928,849 compared to USD 2.069 million a year ago. Operating loss was USD 2.639 million compared to USD 3.180 million a year ago. Net income was USD 9.071 million compared to USD 2.121 million a year ago. For the half year, sales was USD 278,157 compared to USD 3.910 million a year ago. Operating loss was USD 7.863 million compared to USD 7.113 million a year ago. Net income was USD 5.177 million compared to net loss of USD 3.670 million a year ago.